Showing results (331-340 of 933) with videos related to

Sort By:
Pageof 94
Leukemia & Lymphoma|February 22, 2018
Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemiaUri Rozovski, David M Harris, Ping Li, et al.
Blood Advances|August 31, 2021
Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapseBachar Samra, Joseph D Khoury, Kiyomi Morita, et al.
Eye (London, England)|March 31, 2019
Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye serviceRichard P Gale, Sajjad Mahmood, Helen Devonport, et al.
American Journal of Hematology|May 15, 2021
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemiaNitin Jain, Abhishek Maiti, Farhad Ravandi, et al.
Oncotarget|May 17, 2018
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 13, 2025
Inferior Outcomes in Acute Lymphoblastic Leukemia With Translocation (14;18)Diane Habib, Elias Jabbour, Alex Bataller, et al.
Oncotarget|September 29, 2018
STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Acta Haematologica|June 11, 2024
Effect of Digital Health Coaching on Self-Efficacy and Patient-Reported Outcomes in Individuals with Acute Myeloid and Chronic Lymphocytic Leukemia: A Pilot Randomized Controlled TrialJennifer Marvin-Peek, Valerie Shelton, Kelly Brassil, et al.
Acta Haematologica|September 26, 2023
Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf RegionSalem H Alshemmari, Mustaqeem A Siddiqui, Ramesh Pandita, et al.
Cancer|October 30, 2003
Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phaseJorge Medina, Hagop Kantarjian, Moshe Talpaz, et al.
Pageof 94